| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental nystatin poisoning |
Causative agent (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional nystatin poisoning (disorder) |
Causative agent (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par la nystatine d'intention indéterminée |
Causative agent (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin adverse reaction (disorder) |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to nystatin |
Causative agent (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin overdose |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental nystatin overdose (disorder) |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional nystatin overdose |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| surdose de nystatine d'intention indéterminée |
Causative agent (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin 500,000units tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin GF/LF/SF 100,000units/mL suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin [gynecological use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin 100,000units pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin [mouth] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin 100,000units pastille |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin 100000 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Topical nystatin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin 1 million unit oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin 100 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin 100 unit/mg cutaneous powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by nystatin |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Metronidazole+nystatin 400mg/10000units tablet+pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing nystatin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Nystatin + triamcinolone acetonide 100000unt/1mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin + triamcinolone acetonide 100000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin + triamcinolone acetonide 10000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing nystatin and tolnaftate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing metronidazole and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Nystatin+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin- and tetracycline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Nystatin 100,000 units/ml oral suspension sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clobetasone butyrate+oxytetracycline+nystatin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clobetasone butyrate+oxytetracycline+nystatin cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental nystatin poisoning |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional nystatin poisoning (disorder) |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocortisone- and nystatin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin-containing product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorhexidine and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Allergy to nystatin |
Causative agent (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing clobetasol and neomycin and nystatin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
Has basis of strength substance (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
Has precise active ingredient |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Nystatin 100000 unit/g cutaneous cream |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 100000 unit/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 100000 unit/g cutaneous ointment |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 100000 unit/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream (clinical drug) |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
False |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Clobetasone- and nystatin- and oxytetracycline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Nystatin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorhexidine and nystatin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing nystatin and tolnaftate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing clobetasol and neomycin and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only clobetasol and neomycin and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only clobetasone and nystatin and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Chlorhexidine and nystatin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only nystatin and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Nystatin and tolnaftate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin and triamcinolone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only metronidazole and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Hydrocortisone and nystatin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only nystatin and tolnaftate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only nystatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only nystatin in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Clobetasol and neomycin and nystatin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only chlorhexidine and nystatin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Nystatin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 500,000units tablet (substance) |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 500,000units tablet (substance) |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 1 million unit oral capsule |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 1 million unit oral capsule |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 100 unit/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 100 unit/g cutaneous ointment |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 100 unit/mg cutaneous powder |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 100 unit/mg cutaneous powder |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 200000 unit oromucosal lozenge |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 200000 unit oromucosal lozenge |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 100000 unit oromucosal lozenge |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin 100000 unit oromucosal lozenge |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nystatin 100000 unit/1 each conventional release vaginal tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nystatin 100000 unit/1 each conventional release vaginal tablet (clinical drug) |
Has precise active ingredient |
True |
Nystatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]